Journal of Clinical Medicine · 2020 · 39 citations · 18 references
Life SciencesImmunologyInfectious DiseasesImmunogeneticsMolecular VirologyVirologyCytokine Gene PolymorphismInnate Immune Gene PolymorphismsRespiratory InfectionsRespiratory Infectious DiseasesViral GeneticsViral InfectionsInterferon Gene PolymorphismsInterferon Gene VariantsInterferon Receptor PolymorphismsSars-cov-2 InfectionSingle-nucleotide PolymorphismsViral Genotype-phenotype AssociationViral Load AssaysViral Load Assessment
The course of SARS-CoV-2 infection ranges from asymptomatic to a multiorgan disease. In this observational study, we investigated SARS-CoV-2 infected subjects with defined outcomes, evaluating the relationship between viral load and single nucleotide polymorphisms of genes codifying for IFNλs (interferon). The study enrolled 381 patients with laboratory-confirmed SARS-CoV-2 infection. For each patient, a standardized form was filled including sociodemographic variables and clinical outcomes. The host’s gene polymorphisms (IFNL3 rs1297860 C/T and INFL4 rs368234815 TT/ΔG) and RtReal-Time PCR cycle threshold (PCR Ct) value on SARS-CoV-2 were assessed on nasal, pharyngeal or nasopharyngeal swabs. Higher viral loads were found in patients aged > 74 years and homozygous mutant polymorphisms DG in IFNL4 (adj-OR = 1.16, 95% CI = 1.01–1.34 and adj-OR = 1.24, 95% CI = 1.09–1.40, respectively). After adjusting for age and sex, a statistically significantly lower risk of hospitalization was observed in subjects with higher RtReal-Time PCR cycle threshold values (adj-OR = 0.95, 95% CI = 0.91, 0.99; p = 0.028). Our data support the correlation between SARS-CoV-2 load and disease severity, and suggest that IFNλ polymorphisms could affect the ability of the host to modulate viral infection without a clear impact on the outcome of COVID-19.
18
Jasper Fuk‐Woo Chan, Shuofeng Yuan, Kin‐Hang Kok et al. · The Lancet · 2020 · 9.6K citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +13
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman, Olfert Landt, Marco Kaiser et al. · Eurosurveillance · 2020 · 8.2K citations · Full text
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen, Di Wu, Wei Guo et al. · Journal of Clinical Investigation · 2020 · 5.1K citations · Full text
Kelvin Kai‐Wang To, Owen Tak-Yin Tsang, Wai-Shing Leung et al. · The Lancet Infectious Diseases · 2020 · 3.4K citations · Full text